Navigation Links
Endobronchial valve significantly improves emphysema
Date:10/22/2007

CHICAGO, Oct. 22 Emphysema patients whose lungs are implanted with a pencil eraser-sized, one-way endobronchial valve experience significantly improved measures of lung function and report better quality of life, University of Pittsburgh School of Medicine researcher Frank C. Sciurba, M.D., reported today at CHEST 2007, the annual meeting of the American College of Chest Physicians. Scientific sessions continue through Thursday, Oct. 25, at the McCormick Place Lakeside Center in Chicago.

Normally, lungs easily expand and contract with breathing. But with emphysema, air sacs in the lungs lose elasticity and become hyper-inflated, resulting in decreased function and a feeling of breathlessness, said Dr. Sciurba, principal investigator of the multi-center trial, known as the Endobronchial Valve for Emphysema Palliation Trial (VENT) and director of the Emphysema Research Center at the University of Pittsburgh. Endobronchial valves can allow these over-distended, diseased portions of lung to deflate, improving overall function.

The 31-center, two-year study ended in April 2006 and involved 321 patients in the United States. In the trial, emphysema patients were randomly assigned to either a treatment or control group. Lung function was re-evaluated at six months using a common clinical measure of the volume of air forcibly exhaled in one second (FEV-1) and a six-minute walk test, said Dr. Sciurba. Of the 220 patients who received valve implants, there was a 6.4 percent greater improvement in FEV-1, and a 5.7 percent improvement in distance walked, compared to controls, he said. For some important subsets of treated patients, the results were even more dramatic, Dr. Sciurba added.

For example, patients who had a fissure completely separating the lobes of the lung and whose endobronchial valves were placed to exclude the entire diseased lobe had changes in FEV-1 of greater than 20 percent, he said. This is akin to the results achieved in
'/>"/>

Contact: Michele D. Baum
BaumMD@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Page: 1 2

Related biology news :

1. Edible bivalves as a source of human pathogens: signals between vibrios and the bivalve host.
2. Bone and cartilage growth to blame for heart valve disease
3. Percutaneous aortic valve replacement safe, successful in high-risk patients
4. COX-2 inhibitors significantly reduce risk of cancer
5. High HPV concentrations combined with smoking significantly raise risks of cervical cancer
6. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
7. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
8. Product improves peptide identification for proteomics research
9. Stem cell treatment improves mobility after spinal cord injury
10. Combination therapy improves AIDS-related lymphoma outcome
11. Cell therapy slows progression of an inherited neurological disease; Improves motor skills in mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2014)... professor of mechanical engineering at Worcester Polytechnic ... university,s Integrative Materials Design Center (iMdc), recently ... leading engineering societies. , At its annual ... association of more than 138,000 engineers and ... and commercial vehicle industries, presented Lados with ...
(Date:4/15/2014)... Texas The global experts who study the deadliest ... and Thomas G. Ksiazek, professors at the University of ... the 6th annual International Symposium on Filoviruses. The filoviruses ... 50 to 90 percent of people infected. The current ... caused more than 100 deaths so far. , ...
(Date:4/15/2014)... (April 15, 2014) The American Association of ... winners. All awards will be presented during the ... Marriott Hotel on Tuesday, April 29th at 7:30 p.m. ... , The 2014 award winners are: ... Laitman, PhD, of the Icahn School of Medicine at ...
Breaking Biology News(10 mins):WPI's Diana Lados honored by SAE International and Minerals, Metals, and Materials Society 2WPI's Diana Lados honored by SAE International and Minerals, Metals, and Materials Society 3WPI's Diana Lados honored by SAE International and Minerals, Metals, and Materials Society 4WPI's Diana Lados honored by SAE International and Minerals, Metals, and Materials Society 5International research group recognizes UTMB experts 2International research group recognizes UTMB experts 3American Association of Anatomists 2014 award winners 2
... mothers can survive over the long-term, according to new research ... . The study shows for the first time that some ... led by a Field Museum scientist working with numerous colleagues ... shark producing multiple offspring that survived. Two daughters of the ...
... Press, and the Infectious Diseases Society of America (IDSA), ... partnership for IDSA,s highly cited and internationally prestigious journals: ... The Journal of Infectious Diseases ( JID ... from 1st of January, 2011. IDSA,s ...
... that live in the mountains are highly likely to die ... relatives in the lowlands are not, according to new research ... of the study, from Imperial College London, the Zoological Society ... suggest conservationists may be able to limit the impact of ...
Cached Biology News:Study of shark virgin birth shows offspring can survive long term 2Oxford University Press enters publishing partnership with Infectious Diseases Society of America 2Living the high life is risky business for toads under threat from fungus 2Living the high life is risky business for toads under threat from fungus 3
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Non-GAAP EPS Increased 22 Percent, CAMBRIDGE, Mass., April 23 ... the first quarter of,2008, which featured excellent revenue growth, continued ... the company., First-Quarter Highlights -- Total revenue ... $883.2 million in same period a ...
... patients treated with PBI-1402 did not require blood ... ... ProMetic Life Sciences Inc.,(TSX: PLI) ("ProMetic") announces that oral PBI-1402 demonstrates,significant ... red blood cell ("RBC") transfusion., Only 2 patients out of ...
... PCOP ), an innovator in the discovery and development ... plans to,release its financial results for the first quarter ... Wednesday, May 7, 2008. The company will,conduct a webcast ... same day., Dr. Joseph A. Mollica, Chairman of ...
Cached Biology Technology:Genzyme Reports Strong First-Quarter Growth 2Genzyme Reports Strong First-Quarter Growth 3Genzyme Reports Strong First-Quarter Growth 4Genzyme Reports Strong First-Quarter Growth 5Genzyme Reports Strong First-Quarter Growth 6Genzyme Reports Strong First-Quarter Growth 7Genzyme Reports Strong First-Quarter Growth 8Genzyme Reports Strong First-Quarter Growth 9Genzyme Reports Strong First-Quarter Growth 10Genzyme Reports Strong First-Quarter Growth 11Genzyme Reports Strong First-Quarter Growth 12Genzyme Reports Strong First-Quarter Growth 13Genzyme Reports Strong First-Quarter Growth 14Genzyme Reports Strong First-Quarter Growth 15Genzyme Reports Strong First-Quarter Growth 16Genzyme Reports Strong First-Quarter Growth 17Genzyme Reports Strong First-Quarter Growth 18Genzyme Reports Strong First-Quarter Growth 19Oral PBI-1402 Demonstrates Significant Activity in Chemotherapy-Induced Anemia Phase II Clinical Trial 2Oral PBI-1402 Demonstrates Significant Activity in Chemotherapy-Induced Anemia Phase II Clinical Trial 3Pharmacopeia to Host First Quarter 2008 Financial Results Webcast and Conference Call 2Pharmacopeia to Host First Quarter 2008 Financial Results Webcast and Conference Call 3
Activating Agents, 7-azabenzotriazol-1-yloxy-tris-(pyrrolidino)phosphonium hexafluorophosphate...
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
...
...
Biology Products: